ScienceDex / Researcher record
Edward Wu
- National Center for Advancing Translational Sciences (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 10% Funded
- Early Career
NIH Funding · FY2025
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2025): $5.7M in linked award amounts across 8 award records · Award-linked rank #1129.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2025 · selected8 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 79990259Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award records by amount
NIH award records listing Edward Wu as a PI. Multi-PI records show the full award amount for context.
- 1ZIATR000502-02ZIAContact PIDevelopment of D3 Antagonist for Substance Use Disorder$1.3Maward amount
- 1ZIATR000503-02ZIAContact PIDevelopment of a Non-Paralyzing BoNT-based Biopharmaceutical for the Treatment of Neuropathic Pain$1.3Maward amount
- 1ZIATR000501-02ZIAContact PITargeting Endosomal GPCR (eGPCR) Signaling Platforms for the Treatment of Chronic Pain$1.3Maward amount
- 1ZIATR000439-04ZIAContact PIAssay Development to Predict Toxicity of Antisense Oligonucleotide (ASO) Therapeutic Candidates for Rare Diseases$617.7Kaward amount
- 1ZIATR000535-01ZIAContact PIRepositioning Basimglurant to Treat Hermansky-Pudlak Syndrome Pulmonary Fibrosis$541.5Kaward amount
- 1ZIATR000572-01ZIAContact PIDevelopment of an Antisense Oligonucleotide (ASO) Delivery Platform for Rare Diseases$328Kaward amount
- 1ZIATR000528-01ZIAContact PIDevelopment of Q203 (Telacebec) for the Treatment of Tuberculosis and Related Mycobacterial Infections$243.6Kaward amount
- 1ZIATR000441-04ZIAContact PIDevelopment of a Robust Bioprocess to Rapidly Produce Griffithsin, a Broad-Spectrum Therapeutic and Preventive Antiviral Candidate$75Kaward amount
Award organization
Organizations that administered FY2025 awards listing Edward Wu as a PI.
FY2025 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardNational Center for Advancing Translational Sciences
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025$5M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #1129
- 2025Entered Top 25% NationallyRanked #1129
- 2025Entered Top 10% NationallyRanked #1129